secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-09-16T20:37:26+00:00
Accession:  0001193125-26-393151
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest's charter amendment vote fails to pass at Sept 15 meeting; reconvenes Oct 14
--------------------------------------------------------------------------------

- Special meeting reconvened Sept 15, 2026; quorum of 10,760,144 shares (72.7% outstanding) present.
- Proposal to replace supermajority voting and allow written consent requires 75% affirmative vote; not achieved.
- Meeting adjourned to Oct 14, 2026 at 12:00 pm ET via webcast; record date remains May 28, 2026.
- Proxies already submitted will be voted unless revoked; no changes to proposal.
- Company engaged Sodali & Co. to assist with proxy solicitation for the vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526393151/0001193125-26-393151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526393151/d151966d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-393151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer